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Abstract
Background: A significant number of individuals with type 2 diabetes mellitus do not receive
comprehensive diabetes care management to maintain optimal health.
Purpose: This project was designed to facilitate provider adherence to the type 2 diabetes
mellitus evidence-based practice standards of care. A primary care practice needs assessment
indicated opportunities to improve care management processes which promote adherence to
current clinical practice guidelines.
Methods: This 10-week quality improvement project provided the clinical staff and provider with
the necessary tools to implement best practices of diabetes care. Objectives assessed throughout
project implementation included the design and use of an electronic health records alert system;
clinical staff and provider participation in a diabetes education session; completion of the
evidence-based comprehensive diabetes management flowsheet with verification by provider and
patient signature; completion of routine laboratory tests such as HgbA1c and annual
microalbuminuria; documentation of preventive measures employed such as medications, annual
exams, and vaccines; and documentation of diet and exercise counseling.
Results: The use of a diabetes flow sheet resulted in decreased HgA1c results greater than 7.0%
with more than half of the patients with type 2 diabetes mellitus having a prescribed preventive
medication, and all patients with a completed flowsheet received diet and exercise education.
Implications for Practice: Incorporating current diabetes standards in the management of patients
with type 2 diabetes can prevent disease-related complications and improve health outcomes.
Keywords: diabetes mellitus type 2, quality improvement, primary health care, evidencebased practice, patient care planning, diabetes complications, diet, diabetes, exercise, glycated
hemoglobin A
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Type 2 Diabetes Mellitus (T2DM) is a chronic condition in which the body is unable to
make or use insulin properly (National Institute of Diabetes and Digestive and Kidney Diseases
[NIDDK], 2016). Diabetes can lead to debilitating complications if not appropriately managed or
left untreated. Adherence to evidence-based diabetes care guidelines are essential to safeguard
the health of each individual with diabetes. In addition to screening for diabetes and its
complications, clinical practice guidelines recommend specific process measures to guide care
and glycemic control targets (Casanova et al., 2016). Effective therapeutic management has been
shown to prevent or delay diabetes-associated complications. However, studies have
demonstrated a breakdown in meeting these goals by patients, healthcare providers, and systems
(Casanova et al., 2016).
Problem
According to the Centers for Disease Control and Prevention (CDC), 30.3 million
individuals within the United States have diabetes mellitus with more than 90% of them having
T2DM (2018). It is estimated that by 2040, the global prevalence of diabetes will climb from 420
million to 642 million people (Reusch & Manson, 2017). This chronic condition predominately
affects adults over the age of 45 but can also be seen in young adults and children (CDC, 2018).
Individuals with diabetes spend twice as much on medical expenses when compared to
individuals who do not have diabetes (American Diabetes Association [ADA], 2014). Some of
the complications associated with diabetes include blindness, kidney failure, heart disease,
stroke, and peripheral neuropathy (ADA, 2014). It is imperative that providers guide individuals
with T2DM to follow preventive measures and promote continuous medical management of the
disease.
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Diabetic guidelines are continually being revised in order to reflect evidence-based
practices for both clinical and preventive efforts. These standards are used to manage and
continuously monitor the disease with routine laboratory work, lifestyle modifications, and
referrals to specialists such as dieticians, ophthalmologists, and podiatrists (Hashmi & Khan,
2016). Use of these standards has been associated with positive changes in patients’ hemoglobin
A1c (HbA1c), lipid levels, and self-management (Hashmi & Khan, 2016). Adherence to diabetic
guidelines has demonstrated the ability to reduce unnecessary healthcare costs (Hashmi & Khan,
2016). Moreover, health services at the systems level can impact the sustainability of these
standards through financial resources, trained staff, policy, and an organizational framework
(Hashmi & Khan, 2016).
Background and Significance
In 2015, the all-states median percentage of U.S. adults aged 18 and older with diabetes
who did not receive two or more HbA1c tests in the last year was 28.6%; 28.4% did not receive
an annual foot exam; 45.6% did not attend a diabetes self-management class; 38.4% did not have
an annual dilated eye exam; and 37% report not completing daily self-monitoring of blood
glucose (CDC, 2017). Processes that enable providers to consistently adhere to best practices in
diabetes clinical care are crucial to improve patient outcomes and eliminate the complications so
frequently associated with this disease. The current clinical practice guidelines for the
management of diabetes support processes which facilitate adherence to evidence-based
practices within a busy internal medicine practice (Handelsman et al., 2015; Riddle et al.,
2018a). Such processes occur when best research evidence is used to identify strategies that will
streamline care and improve patient outcomes. The 2018 ADA and 2015 American Association
of Clinical Endocrinology and American College of Endocrinology (AACE/ACE) clinical
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practice guidelines provide recommendations for the management of diabetes to improve health
outcomes (Handelsman et al., 2015; Riddle et al., 2018a).
Assessment
A microsystem assessment was performed at a fast-paced internal medicine practice to
evaluate T2DM management. The practice consists of two clinics located within rural
communities in South Central Texas on the southside of San Antonio. The purpose of the
internal medicine practice is to prevent, diagnose, and treat diseases affecting the adult
population within these areas. The practice promotes the concept of a patient-centered medical
home (PCMH) and education to establish lasting patient-provider relationships with their
patients. PCMHs encompass comprehensive, patient-centered, coordinated care, accessible
services, quality, and safety (Ackroyd & Wexler, 2014). Furthermore, PCMHs promote care of
the whole patient boosting both patient and provider satisfaction (Ackroyd & Wexler, 2014).
The internal medicine practice managed the care of more than 4,260 patients at the two
clinics in 2017. The majority of the practice’s clients are White, Hispanic/Latino descent, male,
and 60-69 years of age (Table 1). Clinic A is located in a community that has a total population
of 26,119 residents (U.S. Census Bureau, 2016). This community’s population is 77.9% White
and 92.1% Hispanic/Latino descent (U.S. Census Bureau, 2016). The median household income
within this zip code is $31,728 with 32% of the population living below the poverty level (U.S.
Census Bureau, 2016). Clinic B is located in a rural community that has a total population of
6,012 residents of which 90% are White and 81% are of Hispanic/Latino descent (U.S. Census
Bureau, 2016). The median household income within this zip code is $39,325 with 25% of the
population living below the poverty level (U.S. Census Bureau, 2016).
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Table 1
Total Practice Patient Population
Demographics

% (n)

Race
Asian

0.4% (20)

White

59.2% (2,522)

Black

2.6% (111)

Other

37.7% (1,608)

Ethnicity
Hispanic

79.8% (3,399)

NonHispanic

20.2% (862)

Less than 20

2.7% (113)

20 – 29

3.2% (138)

30 – 39

7.1% (304)

40 – 49

11.5% (492)

50 – 59

21.8% (930)

60 – 69

26.3% (1,122)

70 – 79

17.4% (743)

80 – 89

8.1% (349)

90 – 99

1.6% (70)

Male

56.9% (2,423)

Female

43.1% (1,838)

Age

Sex

The practice includes one physician with more than 30 years of medical practice
experience, three full-time medical assistants (MAs), two receptionists, one information

11
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technology administrator, one office manager, and one finance administrator. The physician
provides care to patients at both clinics. A second provider position is currently open. The most
common International Classification of Disease, Tenth Edition (ICD-10) codes billed by the
provider at these sites are illustrated in Table 2.
Table 2
Top 6 ICD-10 codes at Clinic A & Clinic B
ICD-10 codes

% (n) of Patients Diagnosed

Hyperlipidemia (E78.2)

16.8% (720)

Primary hypertension (I10)

16.0% (684)

T2DM with hyperglycemia (E11.65)

7.3% (313)

T2DM with neuropathy (E11.43)

4.5% (193)

Atherosclerotic heart disease (I25.118)

3.9% (168)

T2DM with Chronic Kidney Disease (E11.22)

3.7% (156)

Clinic Processes Prior to Intervention
The practice uses a collaborative approach in order to maintain efficient patient flow.
Clinic A examines 17 to 30 patients per day and Clinic B examines approximately 5 to 17
patients per day, respectively. The practice accepts most insurance plans and welcomes walk-ins.
Patient charts are prepared 2 to 3 days prior to the patient’s scheduled appointment by MAs. For
most patients, the information technology administrator or MAs manually input one day prior to
patient appointments the guideline-recommended patient exams, vaccines, or medications for the
provider within the individual patient’s electronic health record. At that time, the receptionist
calls the patients to confirm their appointment. The MAs review charts and input pertinent
information within an established patient intake sheet or establish a new patient intake sheet. The
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prepared chart contains a pre-filled intake sheet, a billing form for the physician to complete, a
copy of the patient’s medications, and a copy of the patient’s previously diagnosed ICD-10
codes. The MAs list the reason for the visit, past medical history, vital signs, vaccines needed,
and previous diagnostic and laboratory exams completed. The provider adds information to the
intake sheet regarding the physical exam, assessment plan, prescribed medications, in-clinic labs
to be performed, preventive screenings to be ordered, and referrals. The provider also completes
the billing form that includes current procedural terminology (CPT) codes, ICD-10 codes, office
procedures, injections, vaccines, referrals, in-clinic laboratory orders, and out-of-clinic
laboratory exam orders. The MAs then review the orders, administer ordered medications or
vaccines, or draw laboratory tests. Once the patient is discharged, the provider gives the chart to
the MAs. The MAs then transfer the billing form to the financial administrator and referral
requests to the office manager. Lastly, the MAs send medication orders to the patient’s
pharmacy.
Practice Patterns
Aside from instituting a patient-centered medical home model approach, the internal
medicine practice is also a member of an accountable care organization (ACO) which focuses on
providing high quality care to their Medicare patients. The provider and practice
manager/information technology administrator work to ensure that the practice remains in
compliance with the most up-to-date clinical guidelines. The practice manager/information
technology administrator reviews insurance panels weekly to evaluate practice metrics.
Additionally, Clinigence software is used to assess daily practice compliance by collecting
clinical data analytics. In evaluating diabetes metrics within Clinigence, it was noted that within
the past year, 31.2% of patients with diabetes had elevated hemoglobin A1c (HbA1c) laboratory

PROVIDER ADHERENCE TO TYPE II DIABETES GUIDELINES

14

results greater than 7%; with 43.8% of patients not having had a laboratory result within the past
6 months. The HbA1c provides information regarding the average amount of blood glucose in
the blood within the past 3 months. The laboratory test is used to diagnose and manage T2DM
(NIDDK, 2018). Normal HbA1c is below 5.7%, prediabetes is 5.7% to 6.4%, and diabetes is
6.5% or above (NIDDK, 2018). Therefore, an in-depth assessment of patients with diabetes was
conducted to assess further change needs.
Purposive samples of diabetic patients were extracted from the electronic health records
(EHR) of the two clinics in order to assess the patients’ current self-management behaviors and
barriers. Two specific sets of patients were selected; Group A consisted of the 125 patients
having obtained HbA1c results in the last 6 months and a HbA1c greater than 7% within the
prior 12 months and Group B consisted of the 176 patients who had not obtained a HbA1c
laboratory result in the last 6 months. Electronic health records were reviewed to identify patient
characteristics within Group A and Group B. Group A’s sample was predominately male,
English speaking, had a HbA1c greater than 9, and a BMI greater than 31 (Table 3).
Twelve patients were randomly selected constituting 10% of the Group A population for
a telephone survey (Appendix A). Nine patients (75%) responded. Of the 9 patients who
responded, 89% verbalized medication adherence, 33% verbalized following a diabetic diet, and
22% exercise most days of the week (Table 4).
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Table 3
Purposive Sample Characteristics
Characteristics

Group A
n = 12

Group B
n = 17

Male

8

11

Female

4

6

English

11

14

Spanish

1

3

Medicare

3

1

Commercial

7

11

Cash

2

5

None recorded

0

4

5.7% - 6.4%

0

2

7% - 7.9%

4

3

8% - 8.9%

1

3

9% +

7

5

18.5 to 24.9

0

1

25 to 29.9

3

1

30 +

9

15

1-2

1

4

3+

11

13

Gender

Primary Language

Insurance

HbA1c

BMI

Number of Comorbidities

15
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Table 4
Group A: Survey Results for Patients with Elevated HbA1c
Response

n (%) Yes

n (%) No

Patients who responded

9 (75%)

3 (25%)

Respondents who scheduled appointment

3 (33.3%)

6 (66.7%)

Respondents who adhere to medications

8 (88.9%)

1 (11.1%)

Respondents who adhere to diet

3 (33.3%)

6 (66.7%)

Nonadherent due to cost

0 (0%)

0 (0%)

Nonadherent due to inconvenience

1 (11.1%)

0 (0%)

Nonadherent due to refusal of diet plan

1 (11.1%)

0 (0%)

Nonadherent due to lack of information

1 (11.1%)

0 (0%)

2 (22.2%)

7 (77.8%)

Respondents who exercise

Seventeen patients were randomly selected from Group B, constituting 10% of this
category, for a telephone survey (Appendix B). Thirteen patients (76%) responded. Of the 13
patients who answered, 31% were seeing another provider, 31% were not notified by staff of the
need for a blood draw for a HbA1c level, and 23% did not provide a reason for failing to obtain a
HbA1c (Table 5).
Barriers identified during the patient telephone survey were the inability to reach selected
patients due to a non-working number and the failure of the patient to return the phone call.
Assessment findings demonstrated an opportunity for improvement in comprehensive diabetes
management. Comprehensive management of T2DM follows evidence-based approaches to care
and acknowledges the patient as a whole including their risks and complications (Garber et al.,
2018).
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Table 5
Group B: Survey Results for Patients Without a Recent HbA1c Laboratory Result
Response

n (%) Yes

n (%) No

Patients who responded

13 (76%)

4 (24%)

Endocrinologist

0 (0%)

0 (0%)

Seeing another provider

4 (30.8%)

8 (61.5%)

Not seeing an MD

1 (7.7%)

Services obtained by respondents

Respondents notified by staff of need for HbA1c

9 (69.2%)

4 (30.8%)

Respondents provided reason HbA1c not obtained

10 (76.9%)

3 (23.1%)

Project Identification
Purpose and Objectives
The purpose of this quality improvement initiative was to implement an evidence-based
approach to facilitate provider adherence to T2DM care management standards. The initiative is
based on the 2018 ADA and 2015 AACE/ACE clinical practice guidelines which encompass
screening recommendations, lifestyle therapy, pharmacotherapy, blood pressure management,
and atherogenic cholesterol particle concentration management (Handelsman et al., 2015; Riddle
et al., 2018a). The project leader and clinical mentor agreed upon the project objectives (Table
6).
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Table 6
Project Objectives, Measurements, and Aims
Objectives

Measurement

1. Project leader and
clinical mentor will
design a
comprehensive
diabetes flowsheet.

Creation of a diabetes flowsheet prior
to project implementation start date.

Diabetes flowsheets will be
available at each nursing station in
Clinic A and Clinic B.

2. Healthcare
provider and MAs
will be provided
education on the
current T2DM
clinical practice
guidelines.

Attendance at a 30-minute education
session.

100% of the healthcare providers
and MAs will attend the educational
session.

3. MAs and provider
will consistently
use the diabetes
flowsheet.

Confirmation of diabetes flowsheet
completion by presence on chart with
provider signature.

Diabetes flowsheet is completed for
70% of patients with T2DM.

4. Increase in
provider adherence
to the use of ADA
and AACE/ACE
diabetes standards.

Increase in documentation of coronary
artery disease prevention treatment,
vaccines, treatment adherence, and
lifestyle management counseling on
diabetes flowsheet and electronic
health record.
An automated EHR alert will notify
the provider of recommended
interventions/orders to be placed for
all patients with T2DM, and the
notification will be disabled once the
intervention/order has been
completed.

70% of patients will have completed
documentation.

5. The information
technology
administrator will
implement an
automated EHR
alert system.

Aims

Alerts will be placed for all patients
with T2DM in need of
recommended orders/interventions.

Aims
The project leader and clinical mentor will collectively design a comprehensive diabetes
flowsheet in accordance with the 2018 ADA and 2015 AACE/ACE diabetes standards. The
flowsheet will be readily available at the start of project implementation at each nursing station
in both Clinic A and Clinic B. The staff within the internal medicine practice will participate in a
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30-minute educational session reviewing the 2018 ADA and 2015 AACE/ACE diabetes
standards, accompanied by information regarding project goals. The aim is to have 100% of the
MAs and the provider attend this session. Additional staff, not required to participate in the
documentation of the standards, will also be invited to participate including the practice
manager/information technology administrator and receptionists. By participating in the session,
they will learn the importance of implementing a diabetes flowsheet developed by the project
leader in collaboration with the clinical mentor based on current evidence. The anticipated
outcome is that 70% of patients with T2DM will have a completed diabetes flowsheet, which
will be verified by provider and patient signature. This flowsheet will assist in increasing
provider adherence to the implementation of the 2018 ADA and 2015 AACE/ACE diabetes
standards. By doing so, the goal is to ensure 70% of patient charts will have documented
counseling, treatment, and preventive measures. Additionally, the information technology
administrator will ensure that an automated EHR alert will be placed for all patients with T2DM
in need of recommended medical exams, laboratory testing, or medications.
Summary and Strength of the Evidence
In the U.S. 14% of adults have diabetes and only 19 to 34% of these individuals are
successfully managed (Del Valle & McDonnell, 2018). Through a search of the literature for the
years 2015 to 2018, no published studies were found that demonstrated an effective,
comprehensive intervention used to facilitate provider adherence to the ADA or ACCE/ACE
diabetes standards. However, many studies demonstrate clinical interventions designed to
facilitate adherence to specific components of the guidelines. These components included
diabetic retinopathy screening, foot exams, and nephropathy screening. Nonetheless, several
studies have demonstrated the effectiveness of implementing a chronic care model approach in
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the primary care setting in order to improve diabetes care management (ADA, 2016; Busetto,
Luijkx, Elissen, & Vrijhoef, 2016; Clement, Harvey, Rabi, Roscoe, & Sherifali, 2013; Del Valle
& McDonnell, 2018). Furthermore, the literature also demonstrated the need for a
comprehensive approach in order to tackle the growing complexity of diabetes care management.
Chronic Care Model
Two recent systematic reviews demonstrate the need for a multifaceted approach to
improving diabetes care management. Clement et al. (2013), demonstrated the need to strategize
diabetes management through use of the Chronic Care Model (CCM). The CCM encompasses
the six components of delivery system design, self-management support, decision support,
clinical information, the community, and health systems (Clement et al., 2013). Canada’s 2018
Clinical Practice Guidelines state that implementing a greater number of CCM components
within diabetes management leads to improved disease outcomes (Clement et al., 2013). The
guidelines also share recommendations for each component that can be used within practice, as
well as a sample diabetes patient care flowsheet within the appendix.
A review of the literature conducted by Busetto et al. (2016), defined integrated care as
an intervention which emphasizes at least two components of the CCM. The review analyzed
various CCM interventions used and their outcomes including an increase in glycemic control,
blood pressure measurements, cholesterol measurements, health service utilization, foot
examinations, and eye examinations (Busetto et al., 2016). Unfortunately, outcome measures and
their association to intervention type could not be determined due to limited studies with similar
outcome measures (Busetto et al., 2016). However, most studies included the decision support
components such as provider education and systems training (Busetto et al., 2016). The provider
education emphasized evidence-based practice and approaches to implementing guidelines.
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Through use of CCM based interventions, 35 of the 44 articles analyzed indicated improved
glycemic control, blood pressure, cholesterol measures, and body mass index (Busetto et al.,
2016). Twenty studies also reported improved process measures such as glycemic control
measurements, foot examinations, cholesterol laboratory results, and eye examinations (Busetto
et al., 2016).
Innovative Approaches
A recent study by McLean et al. (2017), consisted of implementing an educational
intervention in seven out of 49 clinic health system locations, in order to improve human
papillomavirus (HPV) vaccination. The study entailed provider and staff education, quarterly
vaccine coverage evaluations, and adjustments in system-wide patient reminders and recall
reports (McLean et al., 2017). The educational session was 30 to 40 minutes long and included
study presentation, department performance, and vaccine updates (McLean et al., 2017). In
addition to verbal education, electronic and hard copies of provider resources and patient
educational tools were provided during the meeting (McLean et al., 2017). The project staff
visited the intervention sites three times during the beginning of the project to provide the
educational meeting and to evaluate project findings (McLean et al., 2017). HPV vaccination
was then assessed in quarterly intervals through patient electronic medical record reviews
(McLean et al., 2017). Study results for the intervention group included an increase in HPV
vaccination from 40.6% to 59.3%, compared to 31.9% to 44.5% in the control group (McLean et
al., 2017). Provider and staff training contributed to the increase in vaccine coverage, however
the use of patient reminders also influenced this change (McLean et al., 2017).
A retrospective study conducted by Umar-Kamara & Tufts (2013), illustrated the use of
practice aids to improve provider adherence to diabetes care standards. Interventions included in
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the study consisted of foot diagram labels to be placed on patient’s flowsheet, templated eye
exam referral letter, and a diabetes flowsheet to track laboratory results and recommended exams
(Umar-Kamara & Tufts, 2013). In addition to labels used as a reminder for providers, a foot sign
was placed on patient exam rooms to inform patients to remove their shoes in order to be
prepared for the exam (Umar-Kamara & Tufts, 2013). Results included an increase in foot and
microalbuminuria screenings, along with an increase in the number of individuals with a HbA1c
< 9% (Umar-Kamara & Tufts, 2013). The study demonstrated that the use of diabetes
flowsheets, clinical reminders, and referral forms can positively impact diabetes management.
A similar study conducted by Pastel, Liu, Homa, Bradley, and Batalden (2009),
implemented a diabetes flowsheet during a 1-year time frame to improve diabetes process
measures. The diabetes flowsheet contained information regarding dates of patients’ previous
routine care (Pastel et al., 2009). This alerted healthcare providers to the care needs of each
patient such as recommended exams and assessment needs (Pastel et al., 2009). After the sheet
was completed, it was then documented in the electronic medical record by the licensed nursing
assistants (Pastel et al., 2009). The patients’ plan of care and continuous treatment management
was then discussed during staff meetings (Pastel et al., 2009). The study resulted in improved
process and outcome measures with an increased percentage of vaccinations administered, foot
examinations completed, and an increased number of patients with improved blood glucose
and/or cholesterol control (Pastel et al., 2009).
A systematic review by Riddle et al. (2018b), demonstrates the significance of
incorporating lifestyle management into diabetes care. It includes medical nutrition therapy,
exercise, and self-management education and support (Riddle et al., 2018b). To optimize the
well-being of patients with diabetes, it is essential to review these components during the initial
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evaluation of the patient, during follow-up visits, and during assessments of health complications
(Riddle et al., 2018b). Studies have demonstrated that diabetes self-management education can
reduce healthcare costs and improve health outcomes (Riddle et al., 2018b). Consistent evidence
also supports weight management as a preventive measure in delaying the progression of
prediabetes and T2DM (Riddle et al., 2018b). By reducing caloric intake, studies have
demonstrated reductions in HbA1c of 0.3% to 2.0% (Riddle et al., 2018b). Additionally,
incorporating physical activity for at least 8 weeks has demonstrated a 0.66% reduction in
HbA1c, with greater intensity exercises having superior reductions in HbA1c (Riddle et al.,
2018b).
In a retrospective study conducted by Konerman et al. (2017), an EHR system prompt
was implemented within 13 primary care clinics. This study sought to improve hepatitis C virus
(HCV) screening and treatment. The EHR prompt served as a reminder to providers to perform
HCV screening for patients who met screening criteria (Konerman et al., 2017). The prompt also
included educational material, order set, and referral to specialty care for those newly diagnosed
(Konerman et al., 2017). The study compared screenings among 52,660 patients, 3-years prior to
EHR-based prompt implementation to post-implementation (Konerman et al., 2017). Three years
prior to the implementation of the prompt, approximately 28% of the patients had been screened
(Konerman et al., 2017). Whereas, 72% of patients were screened 1-year post-implementation of
the prompt (Konerman et al., 2017). The process included the MA gathering patient information,
discussing screening criteria, and asking the patient about prior screenings and results
(Konerman et al., 2017). Next, the provider reviewed patient charts, completed the EHR-based
prompt, discussed HCV screening with patient, and ordered the Hepatitis C Antibody Test
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(Konerman et al., 2017). Lastly, the provider reviewed the result and acted according to the
result. This study demonstrated the positive impact of an EHR-based alert system.
Methods
From September 11, 2018 to October 1, 2018, a pre-intervention purposive sample was
extracted in order to conduct patient surveys among those with T2DM from September 1, 2017
to September 1, 2018. Two groups were surveyed with a total of 22 phone surveys conducted.
Data analysis demonstrated that of the patients with an elevated HbA1c, 11% did not adhere to
medication treatment, 67% did not follow a diabetes diet, and 78% did not perform the
recommended amount of daily physical activity. Additionally, of the patients without a recent
HbA1c laboratory result, 31% were not notified by medical staff of the need to have a test done.
Table 7
Project Objectives
Intervention

Current Adherence

Anticipated Adherence

Development of diabetes flowsheet

0%

100%

Staff education 2018 Diabetes Standards

0%

100%

Increased deployment of Alert System

50%

75%

Implementation of diabetes flowsheet

0%

70%

Implement weekly performance meetings

0%

70%

Four interventions were chosen to assist in the facilitation of provider adherence to
diabetes standards (Table 7). The first intervention was the creation of a comprehensive diabetes
flowsheet and its implementation process. The second intervention included education for the
staff and physician. The third intervention was to create EHR alerts with recommendations to
implement ADA guidelines by ordering needed annual exams, routine laboratory blood work,
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referrals, or medications. The fourth intervention included the implementation of the diabetes
flowsheet which operated as a guide centered around the use of current diabetes guidelines.
Roles and responsibilities for each intervention were discussed and assigned (Table 8).
Table 8
Roles and Responsibilities
Intervention

Responsible Individual

Design diabetes flowsheet

Project leader
Clinical mentor

Designate standardized alerts

Project leader
Clinical mentor
Practice Manager/IT Administrator

Develop and provide education for providers and staff

Project leader

Participate in diabetes guidelines and project education

Providers
MAs
Receptionist
Practice Manager/IT Administrator

Activate alert system

MAs
Practice Manager/IT Administrator

Complete diabetes flowsheet

MAs
Providers
Receptionist

Evaluate weekly performance reports

Project leader
Clinical mentor
IT Administrator

Education Session
Education was conducted at Clinic A on January 21, 2019 and at Clinic B on January 22,
2019. The education for the healthcare provider included a review of the ADA (2018) and the
AACE/ACE (2015) clinical practice guidelines (Handelsman et al., 2015; Riddle et al., 2018a).
A copy of the clinical practice guidelines was provided to the physician with the section entitled
Components of the comprehensive diabetes medical evaluation at initial and follow-up visits

PROVIDER ADHERENCE TO TYPE II DIABETES GUIDELINES

26

highlighted (Riddle et al., 2018a). The clinic visit process changes for patients with diabetes
were reviewed and discussed including staff responsibilities, the EHR alert system, and the
healthcare provider responsibilities. The diabetes flowsheet outlining the in-clinic measures to be
completed, documentation of counseling patients about preventive health and medications, along
with referrals and follow-up care were discussed in detail (Appendix C).
Education of the MAs included the process changes for clinic visits of patients with
diabetes. The MAs were instructed on patient measurements and sections of the diabetes
flowsheet to be completed prior to clinician examination of the patient. Once the top section of
the flowsheet was completed by the MA, the MAs would provide the patient with diet/exercise
counseling sheets and instruct them to remove their shoes and socks in preparation for the
provider’s examination of their feet. Then prior to leaving the room, the MA would turn on a
designated diabetes video via a handsfree tablet within the patient’s examination room pertaining
to the patient’s learning needs such as diabetes management, diet, or exercise.
The receptionists were educated on the bottom section of the flowsheet. Once the
flowsheet was signed by the provider and patient, the receptionist would then schedule the
patient’s follow-up appointment, inform the patient of referrals to be placed, and provide the
patient with out-of-clinic laboratory orders and fasting instructions.
The financial administrator was informed about the implementation of the diabetes
flowsheet. The administrator then educated the MAs on proper coding of diabetes flowsheet.
Current procedural terminology (CPT) codes used for this process included care planning by the
provider and CCM timed service.
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Alert System
In order to facilitate adherence to the diabetes guidelines, an EHR alert system was
designed to remind healthcare providers of required patient interventions for patients with the
ICD-10 codes of T2DM with hyperglycemia (E11.65), T2DM with neuropathy (E11.43), and
T2DM with chronic kidney disease (E11.22). The information technology administrator was
asked to input needed measures within the patient’s EHR 2 weeks prior to the patient’s
appointment. These patients included those with ICD-10 code E11.65. As the provider enters the
patient’s EHR an alert will appear with laboratory tests, annual exams, vaccines, or preventive
medications due for request or renewal. This reminder assisted the provider to incorporate
guideline-specific orders or preventive measures. The MA would then follow-up on the orders.
Diabetes Flowsheet
A diabetes management flowsheet with laboratory and preventive measures was created
by the project leader and clinic mentor as a tool to facilitate the adherence to diabetes standards.
The information within the diabetes flowsheet was based on the updated diabetes standards and
the NIDDK (Garber et al., 2018; NIDDK, 2007; Riddle et al., 2018a). The flowsheet is formatted
to follow the flow of routine visits and visit preparation making it easy for the MAs and provider
to read and complete. The top section of the form consists of information that would be pre-filled
by the MA including patient identifiers, vital signs, and results of laboratory tests and exams.
The MA can highlight laboratory tests, vaccines, or medications needed as a method of
reminding the provider to order, if indicated by guidelines of time, absence of results, etc. The
MA places the diabetes management flowsheet at the front of the chart for the provider to see.
The flowsheet included additional spaces for documentation on the sheet including assessments
to be completed at each visit, preventive measures, counseling, referrals, and follow-up care. The
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provider completes the therapeutic treatment plan and reviews the plan with the patient. The
provider and patient then sign the sheet as an indication of its completion and agreement to
recommendations. The MA then scans the flowsheet into the patient’s EHR.
Organizational Barriers and/or Facilitators
An organizational barrier to the implementation of the diabetes management flowsheet
was the daily volume of patients at the clinics, which resulted in a quick turnaround of patients.
This resulted in limitations on the time for needed patient education and counseling. An
additional barrier included the heavy workload and responsibilities of the MAs. Therefore, to
avoid an increased workload, the MAs were not required to initiate an additional intake sheet if
the patient was there for a follow-up visit.
Patient barriers included low socioeconomic status, language, and low health literacy.
Often patients did not have current laboratory results, exams, or poorly controlled diabetes due to
lack of funding. Additionally, more than half of the patients evaluated did not speak English.
Patients who were non-English speakers with low health literacy demonstrated poor compliance
with their diabetes treatment plan.
Facilitators included the physician’s support of improvement initiative which helped gain
support from the clinical staff. The practice manager/information technology administrator
assisted in the implementation of automated EHR alerts and review of data analysis.
Furthermore, use of the EHR to electronically collect data was an additional facilitator. The
collaborative team effort and technological support increased adherence to the ADA (2018) and
the AACE/ACE (2015) clinical practice guidelines.
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Results
A chart audit checklist based on the diabetes care standards was created to assess the
impact of project implementation. Chart audits were conducted once weekly during the 10-week
duration of project implementation from February 4, 2019 to April 12, 2019. A total of 186
charts were reviewed throughout project implementation. The variables evaluated postimplementation included the design and implementation of the comprehensive diabetes
flowsheet; design and implementation of automated EHR alerts; MA and provider participation
in the diabetes education session; completion of diabetes management flowsheet verified by
provider and patient signature; completion of routine laboratory tests such as HgbA1c and annual
microalbuminuria; documentation of preventive measures such as medications, annual exams,
and vaccines; and documentation of diet and exercise counseling.
Objective 1: The project leader and clinic mentor will design a diabetes flowsheet to use
for every patient with T2DM. Results: A diabetes flowsheet was created to facilitate therapeutic
treatment documentation of recommended measures for patients with T2DM. It included
recommended laboratory measures, preventive medications, preventive annual exams, vaccines,
and patient education. Patients excluded from this process included patients with T2DM that
came to the clinic due to an acute illness.
Objective 2: The healthcare provider and MAs will participate in the diabetes educational
session on the current T2DM clinical practice guidelines. Results: All of the MAs and the
healthcare provider participated in a 30-minute education session, discussed the standards, and
reviewed processes. The project leader conducted individual evaluations of the processes prior to
project implementation.
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Objective 3: MAs and providers will consistently use the diabetes flowsheet for 70% of
patients with T2DM seen in the 10-week time period. Results: Diabetes flowsheets were
completed for 81.7% of the 186 patients diagnosed with T2DM seen during the implementation
period. Figure 1 demonstrates weekly provider performance of diabetes flowsheet completion
following the MA initiating the form.
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Figure 1. Diabetes flowsheets completed.
Objective 4: The provider will adhere to the 2018 ADA and 2015 AACE/ACE diabetes
standards for 70% of patients as evidenced by documentation completion. Results: Of the 186
patients with T2DM that were seen, 97.8% of patients had documented diet and exercise
counseling. In reviewing preventive medications prescribed to patients with a completed diabetes
flowsheet, it was noted that 68.4% of patients were prescribed an ACE/ARB; 75.7% were
prescribed a statin medication; and 56.6% of patients were prescribed aspirin (Figure 2). The
percent of patients with a documented annual microalbuminuria, annual diabetes eye exam,
current influenza vaccine, and current pneumococcal vaccine was also demonstrated (Figure 3).
Lastly, approximately 32.7% of patients had a documented foot exam.

Percent of Patients
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Figure 2. Percentage of patients on preventive medications.
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Figure 3. Percentage of patients with documented preventive measures.
The HbA1c laboratory results among patients with T2DM were compared preimplementation and post-implementation of the quality improvement project to enhance provider
adherence to evidence-based practices. It was noted that there was a decrease in the percent of
patients with HgA1c results greater than 7.0% post-implementation (Figure 4).
Throughout the implementation process the clinic had the ability to bill patients for
chronic care management services, CPT code 99487, and individualized care planning, CPT
code G0506. Chronic care management billing, CPT code 99487, assumed 60 minutes of clinical
staff time for the ongoing management and decision-making related to moderate-high complex
patients (Department of Health and Human Services, 2016). If the provider spent more time with
the patient’s diabetes management, code 99489 would be used for an additional 30 minutes, or
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99490 would be used for an additional 20 minutes. Clinic reimburesements were dependant upon
the individuals insurance plan. Approximately 61.8% of patients were billed for chronic care
management services and/or individualized care planning during the 10-week implementation
process. Weekly percent of patients billed for chronic care management demonstrates fluctuation

Percent of Patients

throughout the project with a general overall increase of CCM services billed (Figure 5).
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Figure 4. HbA1c pre- vs. post-implementation.
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Objective 5: The information technology administrator will implement an automated
EHR alert system for all patients with T2DM. Results: This objective was met. Previously, the
information technology administrator or MAs would input alerts manually in to the EHR.
Currently, all patient EHRs with T2DM have an automated alert system to notify the provider of
recommended measures that the patient may be missing according to diabetes standards.
Discussion
Provider and staff participation resulted in an understanding of the importance of
adherence to the 2018 ADA and 2015 AACE/ACE clinical practice guidelines which encompass
screening recommendations, lifestyle therapy, pharmacotherapy, blood pressure management,
and atherogenic cholesterol particle concentration management (Handelsman et al., 2015; Riddle
et al., 2018a). Through the implementation of education and process improvement, both provider
and staff created positive changes in the management of patients with T2DM as also seen in the
study by Pastel et al. (2009). Studies, including Pastel et al. (2009), recommended the use of the
CCM to assist providers to focus on self-management support, clinical information, delivery
system design, decision support, health systems, and community resources. The CCM model was
the basis of this project’s integration of diabetes standards of care into a comprehensive diabetes
flowsheet along with the incorporation of an active EHR alert system.
Overall, adherence to the current diabetes standards remained steady over the
implementation time period. Weekly progress reviews enabled the provider, MAs, and practice
manager to determine areas requiring additional process improvement. As asserted by Pastel et
al. (2009) self-awareness and process change enables the provider and staff to positively improve
care. Of the 152 patients that had a completed diabetes flowsheet, 10.5% did not have a
documented HbA1c. This result is approximately 18.1% lower than the all-states median
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percentage of 28.6% U.S. adults that did not receive two or more HbA1c tests in the last year
(CDC, 2017). Due to the high volume of patients seen, foot assessments were often missed. This
resulted in 67.3% of patients not receiving a foot exam. This result is 38.9% greater than the allstates median percentage of 28.4% in U.S. adults (CDC, 2017).
Incorporation of a therapeutic treatment plan into the flowsheet provided the patient
written clarification of preventive measures. All patients with a completed diabetes flowsheet
received diet and exercise counseling aligned with their personal needs. In accordance with
Riddle et al. (2018b) individuals in need of weight loss were encouraged to reduce their caloric
intake to 1,200 to1,500 kcal/day for women and 1,500 to1,800 kcal/day for men depending on
their baseline weight. The provider was prompted by the flowsheet to provide each patient with a
diet recommendation and a one-week sample meal plan in accordance with their caloric needs.
The provider was also prompted to recommend exercise time and examples of physical activity
that could be completed in a safe manner.
Sustainability of the diabetes flowsheet is fortified by the increased revenue through the
use of chronic disease management codes. The practice had the opportunity to receive
reimbursement for approximately 94 patients during the 10-week implementation process.
Limitations
There were limitations noted throughout the implementation of the project. First, the
practice, which consists of two busy clinics, only had one provider and is currently seeking an
additional provider. Consistently high volumes of patients resulted in heavy workload and
responsibilities among the MAs. The heavy workload of the clinical staff could have precipitated
18.3% of the 186 patients not having a diabetes flowsheet completed or resulted in the failure to
instruct patients to remove their shoes as a reminder for the provider to complete a foot
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assessment. Additionally, the practice predominately saw patients of Hispanic descent with both
language and economic barriers. The low health literacy and financial burden among patients
may have been the result of their inability to obtain needed laboratory testing and annual exams.
This quality improvement initiative demonstrated that a multifaceted approach can
improve therapeutic management for individuals with T2DM. However, with only 32.7% of
patients having their feet assessed during implementation period, it is recommended that further
education be provided to clinical staff about the importance of foot exams. Providing the clinical
staff with visual cues as a reminder of ensuring that preventive measures for each patient are
assessed could result in a greater number of patients having their feet assessed (Clement et al.,
2018; Umar-Kamara & Tufts, 2013). The practice could use labels on the flowsheet as a
reminder for providers and a foot sign placed on patient exam rooms to inform patients to
remove their shoes (Umar-Kamara & Tufts, 2013).
Recommendations
Ongoing performance improvement review of the measures related to comprehensive
diabetic care is needed to ensure advancement in the management of patients with T2DM.
Weekly process reviews by administrative staff and the practice provider will aid in updating
measures within the diabetes flowsheet. Through process reviews, the practice will also identify
barriers to care and facilitators that will further enhance the management of patients with T2DM.
Therefore, review meetings will also guide the provider in delivering appropriate individualized
treatment plans.
These reviews should be accompanied by continuing staff education on the implications
of T2DM standards of care to ensure sustainability of the diabetes flowsheet. The

PROVIDER ADHERENCE TO TYPE II DIABETES GUIDELINES

36

implementation of the diabetes flowsheet should also become a component of new staff
orientation.
Providing consistent patient education can also ensure greater self-management support
and increase health awareness. This can be done through review of previous flowsheets within
the patient’s EHR to identify areas in need of reinforced patient knowledge. Such areas include
diet, exercise, importance of obtaining necessary laboratory tests and exams.
Implications for Practice
Incorporating current diabetes standards in the management of patients with T2DM can
significantly prevent complications and improve health outcomes. The doctorally-prepared nurse
practitioner can effectively assess care processes to improve patient care within a clinical setting.
The use of a diabetes flowsheet can positively increase provider adherence to T2DM standards of
care.
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Appendix A: Survey Questions for Patients with Elevated HgbA1c Results
Patient’s Name:

No answer: 1 2 3

LM

Returned call

Survey Questions for patients with elevated HgbA1c results:
Hello, my name is

. I am a nurse working with Dr. Rocha,

calling his patients to see how they are doing. We noticed that your last visit with him was ____
and you are scheduled to see him again on

________. Will you still be able to come to this

appointment?
Scheduled Date: ____________
Not Scheduled: Reason: ________________
Let’s review your diabetes medications. Are you taking the diabetic medications at the times the
Next Appointment:

doctor prescribed?
Medication

Dosage

Frequency

Have you made any changes in your Diabetes medications? If so, is there a reason why you are
not taking them as prescribed? If no changes: It’s great to hear that you are taking the medication
as prescribed.
No
Yes
No insurance coverage

Changes to medications:
Cost
If yes:

Lack of support

Lack of organization

Blood sugar high

Blood sugar low

Are you following the instructions for a diabetic diet?
Diet:

Forgot

Cost

Inconvenient

Lack of information

Yes

Knowledge deficit

No

Refuses to follow diet

Diet Consult needed

Information needed

How many days a week do you exercise for 30 min?
Exercising:

0

1

2

3

4

5+
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Appendix B: Survey Questions for No HbA1C Within the Past 6 Months
Patient’s Name:

No answer: 1 2 3

LM

Returned call

Survey Questions for no HbA1C within the past 6 months:
Hello, my name is

. I am a nurse working with Dr. Rocha, calling his

patients with diabetes. We noticed that your last visit with us was

. Are you

receiving your medical care at a different facility?
Services:

Endocrinologist

Seeing another PCP

If not: We see that your last hemoglobin A1c was

Not currently seeing an MD
, and that was done

. This is a lab result that needs to be done every 3 months in order to help you control
your diabetes. Did the staff ask you during your last visit to take a blood test for your Diabetes?
HbA1c:

Asked by staff

Not asked by staff

If so: Is there a reason why you were unable to have it done?
Reason lab not complete:

Cost

No insurance coverage

Transportation

Inconvenient

Refusal
Forgot

Lab site not provided
If not: When would you be able to have your blood test done so we can schedule you for a
follow-up visit to help you with your Diabetes?
Next Appointment:

Scheduled Date: ____________
Not Scheduled: Reason: ________________
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